November 2-4, 2007
Wynn Hotel & Casino
3131 Las Vegas Blvd.
Las Vegas, NV 89109

Register Online Now!

Overview/Need

Breast, cervical and ovarian cancers are three of the most common cancers among American women, with over 212,060 newly diagnosed cases and 45,658 deaths projected for 2007 by the Cancer Institute.  Colorectal cancer will be diagnosed in another 74,630 American women and an estimated 26,180 will die of the disease by the end of 2007, making colorectal cancer the third leading cause of cancer death among American women. Recognizing that patient quality of life and survival rates for these cancers are significantly improved when they are detected early and treated appropriately. There is a need for physicians to remain current on the rapidly evolving approaches to their diagnosis and treatment. 

This year City of Hope, an NCI-designated Comprehensive Cancer Center has partnered with the Nevada Cancer Institute, the official cancer institute for the State of Nevade; to bring to our learners the expertise of faculty from these two noted cancer research and treatment center.  Designed by these experts in the fields of gynecologic, breast and gastrointestinal oncology.  The Seventh Annual City of Hope Women's Cancer Conference will address the educational needs of physicians who diagnose and treat women with these cancers.  Advances in key screening and diagnostic areas will be examined and changes in treatment recommendations paradigms will be profiled and discussed. We welcome and invite your participation and valuable contribution to our conference.

Objectives 

Upon successful completion of this educational activity, participants should be better able to:

• Discuss advances in screening, prevention and treatment of cervical cancer
• Review surgical and systemic treatment options for ovarian cancer
• Evaluate clinical implications of cultural competence on cancer care in women
• Describe in implications and utility of adjuvant therapy for breast cancer in the elderly and in early stage patient populations
• Examine AIDS related malignancies in women
• Identify the role of BRAC1/BRACA2 in familial breast cancer
• Assess the benefits of minimally invasive surgical techniques and newer targeted therapies for the treatment of colorectal cancer
• Debate the role of IP therapy for the treatment of peritoneal malignancies

Expected Results
It is the intent of our educational activity to provide physicians and allied health care providers with objective, evidence-based clinical content, which they can incorporate into their treatment strategies to improve the clinical care and outcomes for their female patients with cancers of the breast, ovary, cervix and gastrointestinal tract .

Who Should Attend

Gynecologists, medical oncologists, radiation oncologists, gastroenterologists, surgeons, surgical oncologists, diagnostic radiologists, internists, family practitioners and other allied health care professionals who treat women with breast, cervical, ovarian and colorectal cancers.

Faculty Disclosure

This activity has been planned and implemented in strict compliance with the Essential Elements and Policies of the Accreditation Council for Continuing Medical Education (ACCME). City of Hope takes responsibility for the content, quality and scientific integrity of this CME activity
 
Prior to their participation in this City of Hope continuing medical education activity all faculty/presenters have disclosed any real or apparent vested commercial interest(s) in both those companies whose products may be discussed during the course of the activity and in those companies acting as commercial supporters of the activity. City of Hope further requires that prior to the activity faculty/presenters have disclosed their intention to discuss any off-label and/or investigational  (not yet approved for any purpose) use of pharmaceuticals or medical devices. Written disclosure of faculty/presenters’ specific commercial relationships and/or intent to discuss “off-label” and/or investigational use will be provided in the activity syllabus

Acknowledgments

This Education Program is made possible, in part, through unrestricted educational grants from Merck, Pfizer, Amgen & Lilly.  This is a partial list.   All companies who support this CME activity with educational grants will be acknowledged in the conference syllabus.

Special Assistance

In compliance with the Americans with Disabilities Act, all reasonable efforts will be made to accommodate persons with disabilities at the meeting. If you have any special dietary or accommodation needs, please notify the course coordinator, Jean Kagan, at 626-256-HOPE (4673), Ext. 65622 prior to the conference. It is important to notify us in advance of your special needs to help us better serve you.